LINK Healthcare establishes regional platform for Early and Expanded Access Programs (EAPs) for the Australasian, Asian & African markets     EAPs make it possible to get vital and life-saving treatments to patients with no other option LINK has signed 12 regional EAP agreements in the last 12 months LINK’s territory covers 33% of the

LINK Healthcare receives “first to market” generic approval for Lignocaine HCl 5% & Phenylephrine HCl 0.5% topical Solution Generic formulation for nasal surgical procedures Latest addition to LINK’s growing generic range of specialist medicines Sydney/Pretoria/Singapore/Tokyo/Auckland: 14th July 2014   Specialist pharmaceutical and medical technologies business, LINK Healthcare (‘LINK’) announced today that it has received marketing